4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-016451
EVP, Chief Development Officer acquired 3,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Forbes William P · EVP, Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-19 | Exercise or conversion : show line 1 in the form | +3,875 | 170,078 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-19 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −3,875 | 30,994 | D |
Loading xslF345X05/ownership.xml…